Back
Apellis Pharmaceuticals Vs. Natera Industry Stock Comparison
Sell
44
APLS
Apellis Pharmaceuticals
Last Price:
28.71
Seasonality Move:
20.78%
Buy
81
NTRA
Natera
Last Price:
154.00
Seasonality Move:
3.03%
Sell
44
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $28.23. The Score for APLS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
81
Natera (NTRA)
is a Buy
Is Natera a Buy, Sell or Hold?
- The current Natera [NTRA] share price is $160.90. The Score for NTRA is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
- NTRA is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $28.23
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
NTRA Stock Price Chart
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 46.19 | Sell |
| Chaikin Money Flow: | -1450356 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.99 - 28.75) | Buy |
| Bollinger Bands (100): | (29.38 - 39.28) | Sell |
NTRA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.6 | Buy |
| Relative Strength Index (14 RSI): | 81.36 | Buy |
| Chaikin Money Flow: | 575579 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (118.54 - 135.54) | Buy |
| Bollinger Bands (100): | (108.16 - 128.76) | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.91 | Sell |
| 20-day SMA: | 28.03 | Buy |
| 50-day SMA: | 30.65 | Sell |
| 200-day SMA: | 43.67 | Sell |
| 8-day EMA: | 28.77 | Sell |
| 20-day EMA: | 28.57 | Sell |
| 50-day EMA: | 30.49 | Sell |
| 200-day EMA: | 40.29 | Sell |
NTRA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 133.67 | Buy |
| 20-day SMA: | 126.59 | Buy |
| 50-day SMA: | 125.86 | Buy |
| 200-day SMA: | 105.32 | Buy |
| 8-day EMA: | 137.09 | Buy |
| 20-day EMA: | 130.38 | Buy |
| 50-day EMA: | 125.47 | Buy |
| 200-day EMA: | 105.77 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.
Natera Earnings Growth & NTRA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.24 per share, and an increase next year of $0.23 per share.
Apellis Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Natera Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||